Abstract
To evaluate the effect of long-term treatment with recombinant human GH(rhGH) on renal function in short children with nephropathic cystinosis with and without concomitant cysteamine treatment, 36 growth-retarded children with nephropathic cystinosis (age 7.3 ± 2.7 y; creatinine clearance(CCR) 50 ± 27 mL (min × 1.73 m2)-1 were treated with 1 IU rhGH/kg/wk for up to 5 y. The rise in serum creatinine before and during rhGH treatment was compared with that in a historical control group of cystinotic patients. The effect of concomitant cysteamine treatment on the evolution of renal function before and after the start of rhGH was evaluated separately in patients without (group A) and with cysteamine treatment (group B). The decline of CCR was also compared with that in noncystinotic patients with chronic renal failure with and without rhGH treatment. At study entry, serum creatinine values in group A were similar to those in the historical controls, whereas group B had significantly lower serum creatinine values. Treatment with rhGH did not accelerate the rise in creatinine independently of cysteamine treatment. There were no significant differences in the mean decline of CCr per year in cystinotic compared with noncystinotic patients with chronic renal failure with or without rhGH treatment. rhGH therapy for up to 5 y does not accelerate the deterioration of renal function. This justifies the continuation of controlled studies of rhGH treatment in these patients. The study also provides further evidence that cysteamine therapy reduces the progression of renal failure in children with cystinosis.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- rh:
-
recombinant human
- CCR:
-
creatinine clearance
- CIN:
-
inulin clearance
- CRF:
-
chronic renal failure
- SDS:
-
SD score
References
Bickel H, Smallwood WC, Smellie JM, Barr HS, Hickmans EM, Harris H, Astley R, Teall GC, Douglas A, Philpott MG, Harvey CC, Finch E 1952 Cystine storage disease with amino-aciduria and dwarfism (Lignac-Fanconi disease). Acta Paediatr 42( suppl 90): 247–257
Broyer M, Guillot M, Gubler MC, Habib R 1981 Infantile cystinosis: a reappraisal of early and late symptoms. Adv Nephrol 10: 137–166
Gahl WA, Schneider JA, Aula PP 1996 Lysosomal transport disorders: cystinosis and sialic acid storage disorders. In: Scriver CR, Beaudet AL, Shy WS, Valle D (eds) The Metabolic and Molecular Bases of Inherited Disease, 7th ed. McGraw-Hill, New York, pp 3763–3782
Markello TC, Bernardini IM, Gahl WA 1993 Improved renal function in children with cystinosis treated with cysteamine. N Engl J Med 328: 1157–1162
Manz F, Gretz N 1994 Progression of chronic renal failure in a historical group of patients with nephropathic cystinosis. Pediatr Nephrol 8: 466–471
Gahl WA, Reed GF, Thoene JG, Schulman JD, Rizzo WB, Jonas AJ, Denman DW, Schlesselman JJ, Gorden BJ, Schneider JA 1987 Cysteamine therapy for children with nephropathic cystinosis. N Engl J Med 316: 971–977
van't Hoff WG, Gretz N on behalf of the British Association for Paediatric Nephrology 1995 The treatment of cystinosis with cysteamine and phosphocysteamine in the United Kingdom and Ire. Pediatr Nephrol 9: 685–689
Winkler L, Offner G, Krull F, Brodehl J 1993 Growth and pubertal development in nephropathic cystinosis. Eur J Pediatr 152: 244–249
Broyer M, Tete MJ, Gubler MC 1987 Late symptoms in nephropathic cystinosis. Pediatr Nephrol 1: 519–524
Haffner D, Wühl E, Tönshoff B, Mehls O for the German Study Group on Growth Hormone Treatment in Chronic Renal Failure 1994 Growth hormone (GH) treatment in short children with chronic renal failure(CRF): a 5 years follow-up. Pediatr Nephrol 8:C40.
Fine RN, Kohaut E, Brown D, Kuntze J, Attie KM 1996 Long-term treatment of growth retarded children with chronic renal insufficiency, with recombinant human growth hormone. Kidney Int 49: 781–785
Wilson DP, Jelley D, Stratton R, Coldwell JG 1989 Nephropathic cystinosis: Improved linear growth after treatment with recombinant human growth hormone. J Pediatr 115: 758–761
van't Hoff WG, Wühl E, Offner G, Mehls O, for the European Study Group 1993 Growth in children with nephropathic cystinosis. Pediatr Nephrol 7( suppl): C7
Andersson HC, Markello T, Schneider JA, Gahl WA 1992 Effect of growth hormone treatment on serum creatinine concentration in patients with cystinosis and chronic renal disease. J Pediatr 120: 716–720
Prader A, Largo RH, Molinari L, Issler C 1988 Physical growth of Swiss children from birth to 20 years of age. Helv Paediatr Acta 52( suppl): S1–S125
Schwartz GJ, Haycock GB, Edelman CM 1976 A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58: 259–263
Wingen AM, Fabian-Bach C, Schaefer F, Mehls O, for the European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood 1997 Failure in Childhood 1997 Randomised multicentre study of a low-protein diet on the progression of chronic renal failure in children. Lancet 349: 1117–1123
Gretz N 1994 How to assess the rate of progression of chronic renal failure in children?. Pediatr Nephrol 8: 499–504
Gahl WA, Schneider JA, Schulman JD, Thoene JG, Reed GF 1990 Predicted reciprocal serum creatinine at age 10 years as a measure of renal function in children with nephropathic cystinosis treated with oral cysteamine. Pediatr Nephrol 4: 129–135
Schneider JA, Clark KF, Greene AA, Reisch JS, Markello TC, Gahl WA, Thoene JG, Noonan PK, Berry KA 1995 Recent advances in the treatment of cystinosis. J Inherit Metab Dis 18: 387–397
Tönshoff B, Mehls O, Heinrich U, Blum WF, Ranke MB, Schauer A 1990 Growth-stimulating effects of recombinant human growth hormone in children with end-stage renal disease. J Pediatr 116: 561–566
Wanke R, Hermann W, Folger S, Wolf E, Brem G 1991 Accelerated growth and visceral lesions in transgenic mice expressing foreign genes of the growth hormone family: an overview. Pediatr Nephrol 5: 513–521
Ritz E, Tönshoff B, Worgall S, Kovacs G, Mehls O 1991 Influence of growth hormone and insulin like growth factor-I on kidney function and kidney growth. Pediatr Nephrol 5: 509–512
Haffner D, Zacharewicz S, Mehls O, Heinrich U, Ritz E 1989 The acute effect of growth hormone on GFR is obliterated in chronic renal failure. Clin Nephrol 32: 266–269
Hokken-Koelega ACS, Stijnen T, De Munch Keizer-Schrama SMPF, Wit JM, Wolff ED, de Jong MCJW, Donckerwolke RA, Abbad NCB, Bot A, Blum WF, Drop SLS 1991 Placebo controlled, double blind, cross-over trials of growth hormone treatment in prepubertal children with chronic renal failure. Lancet 338: 585–590
Fine RN, Kohaut EC, Brown D, Perlman AJ, for the Genentech Cooperative Study Group 1994 Growth after recombinant human growth hormone treatment in children with chronic renal failure: report of a multicenter randomized double-blind placebo-controlled study. J Pediatr 124: 374–382
Kainer G, Nakao M, Massie FS Jr, Foreman JW, Chan JC 1991 Hypercalciuria due to combined growth hormone and calcitriol therapy in uremia: effects of growth hormone on mineral homeostasis in 75% nephrectomized weanling rats. Pediatr Res 30: 528–533
Black J, Stapleton FB, Roy S, Ward J, Noe HN 1986 Varied types of urinary calculi in a patient with cystinosis without renal tubular acidosis. Pediatrics 78: 295–297
Tönshoff B, Tönshoff C, Mehls O, Pinkowski J, Blum WF, Heinrich U, Stover B, Gretz N 1992 Growth hormone treatment in children with preterminal chronic renal failure: no adverse effect on glomerular filtration rate. Eur J Pediatr 15: 601–607
Acknowledgements
We thank Pharmacia & Upjohn, Stockholm, Sweden, for providing recombinant hGH (Genotropin®), and we thank Birgitta Lange-Sjöblom for help in organizing yearly study meetings.
Author information
Authors and Affiliations
Consortia
Rights and permissions
About this article
Cite this article
Wühl, E., Haffner, D., Gretz, N. et al. Treatment with Recombinant Human Growth Hormone in Short Children with Nephropathic Cystinosis: No Evidence for Increased Deterioration Rate of Renal Function. Pediatr Res 43, 484–488 (1998). https://doi.org/10.1203/00006450-199804000-00008
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/00006450-199804000-00008
This article is cited by
-
Renal effects of growth hormone in health and in kidney disease
Pediatric Nephrology (2021)
-
Long-term growth hormone treatment in short children with CKD does not accelerate decline of renal function: results from the KIGS registry and ESCAPE trial
Pediatric Nephrology (2015)
-
Cystinosis: practical tools for diagnosis and treatment
Pediatric Nephrology (2011)
